Viridin B, a bacteriocin produced by Streptococcus mitis (S. mitior) strain 42885, has been described previously (3) (4) (5) (6) . The earlier studies were done by using a partially purified preparation which contained bactericidal and hemolytic activities (5) . Both activities coexisted in successive purification steps.
Brock and Davie (2) described a bacteriocin from Streptococcus faecalis subsp. zymogenes strain X-14 which had hemolysin activity associated with the bactericidal activity. They used genetic and physiological evidence to show that the hemolysin was probably the same molecule as the bacteriocin.
We investigated whether the hemolytic and bactericidal activities from S. mitis strain 42885 were identical or distinct products. Data are presented in this report which show that the two activities are the result of two separate proteins. Viridin B was highly purified, and its molecular weight was determined.
MATERIALS AND METHODS
Bacterial strains. S. mitis (S. mitior) strain 42885, which produces viridin B, and Neisseria sicca strain 15362, which is killed by viridin B, have been previously described in detail (4 6 liters of broth were collected by centrifugation at 2,500 x g for 20 min, washed in phosphate buffer, and resuspended in 50 ml of the same buffer. The cells were then stirred vigorously at 4°C on a magnetic stirring platform for 24 to 48 h. The mixture was centrifuged at 13,000 x g for 90 min. The supematant fluid was brought to 80% ammonium sulfate saturation and then centrifuged at 13,000 x g for 60 min. The resulting precipitate was dissolved in 25 ml of phosphate buffer, dialyzed for 18 h at 4°C against the same buffer, and sterilized by filtration through a 0.45-jim membrane filter (Milipore Corp.). Such preparations had both bacteriocin and hemolysin activities and were stored at -20°C until used.
Mutagenesis. The mutagenic agents used were 1-methyl-3-nitro-1-nitrosoguandine at 100 to 500 ug/ml (8), 1 M nitrous acid (11) , and ultraviolet light at a dose allowing approximately 1% survival. S. mitis cells grown in broth to a logarithmic phase were exposed to the various mutagenic agents. Cells were then subcultured onto sheep blood agar plates. After 18 to 24 h of incubation, colonies were screened for alpha-hemolytic activity. For each mutagenic agent 1,000 to 10,000 colonies were screened. Similarly, 100 to 200 colonies were tested for bacteriocin production after exposure to each mutagen by using the simultaneous antagonism technique (4) .
Polyacrylamide gel electrophoresis. Polyacrylamide gel electrophoresis was performed as described by Weber and Osborn (10) . Sodium dodecyl sulfate and /i-mercaptoethanol were omitted from the gels and buffer when assay for the bacteriocin was made, because both substances were inhibitory to the indicator strain. Generally, gels with a final acrylamide concentration of 5% were used with 0.1 M sodium phosphate, pH 7. of the bacteriocin preparations at each stage of purification were tested. Electrophoresis was carried out at room temperature for 4 h. Gels were stained with Coomassie brilliant blue (Bio-Rad Laboratories, Richmond, Calif.) or sliced into 1.5-mm slices and tested for bacteriocin or hemolysin activity as described below.
Bacteriocin assay. Viridin B was assayed after polyacrylamide gel electrophoresis by slicing the gel into 1.5-mm sections. The slices were placed on a lawn of N. sicca strain 15362, and the plates were incubated at 37°C. A clear zone of inhibition around the gel slice indicated the presence of viridin B. Column chromatography fractions were assayed for viridin B activity, and arbitrary units were determined as described earlier (4).
Hemolysin assay. The hemolysin assay was a modification of that reported by Basinger and Jackson (1). Human erythrocytes were washed three times with phosphate-buffered saline and suspended at 0.12% (vol/vol) in phosphate-buffered saline. Gel slices, as described above, were each placed into 0.8 ml of erythrocyte suspension. The samples were incubated for 18 h at 37°C and then centrifuged at 3,000 x g for 3 min. The supernatant fluid was read at 541 nm to detect released hemoglobin. Fractions after DEAE-Sephadex chromatography were also assayed for hemolysin activity. A 0.5-ml portion of each fraction was dialyzed against phosphate-buffered saline for 4 h, mixed with an equal volume of erythrocyte suspension, and incubated at 37°C for 30 min. The samples were then centrifuged, and the supernatant fluid was read at 541 nm. Sephadex G-200 fractions were assayed for hemolysin activity by an identical procedure. A hemolytic unit is the reciprocal of the highest dilution contained in 1 ml of a preparation producing detectable hemolysis (i.e., an optical density reading of m0.1 at 541 nm).
Protein determination. Protein content after each purification step was determined by the method of Lowry et al. (7) . (Fig. 3) . The hemolytic activity could also be detected in one or two slices from another gel. In a typical electrophoresis, the hemolysin was detected 18 mm from the origin, whereas the bacteriocin was located 15 mm further. Figure 4 shows polyacrylamide gel electrophoresis patterns for three preparations after different purification procedures. It is evident that the bacteriocin and hemolysin are two distinct moieties.
RESULTS
The molecular weight of viridin B after DEAE-Sephadex A-50 chromatography was determined to be 87,000 ± 3,000 by polyacrylamide gel electrophoresis with sodium dodecyl sulfate (10) . The protein markers used were human immunoglobulin G (molecular weight, 160,000), bovine serum albumin (68,000), the H chain of immunoglobulin G (50,000), and the L chain of immunoglobulin G (22,000).
DISCUSSION
Since the identity of a bacteriocin with a hemolysin has been suggested in a strain of Streptococcus faecalis (2) Viridin B was shown to have a molecular weight of approximately 87,000, placing it at the intermediate position. Compared with bacteriocins of similar molecular weights, viridin B has several unusual properties, including heat lability, narrow pH range of activity, and either a bactericidal or bacteriostatic effect, depending on the indicator strain (3, 4) .
Although bacteriocin production has been reported for a large number of bacteria generally and for streptococci specifically (9) , only a few bacteriocins have been highly purified. A major problem in bacteriocin purification is the increasing lability upon increased purification (9) . The addition of albumin or other proteins to a bacteriocin preparation during purification steps has enabled increased stability. Viridin B did exhibit marked lability upon purification; however, it was highly purified and was separated from most other extracellular products.
